CIK 0000894158 · Non-accelerated filer<br>Smaller reporting company
Theriva Biologics, Inc.
Sign in to watch- Ticker
- TOVX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 133808303
- Phone
- (734) 332-7800
- Business address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
- Former names
- Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-15 | Wolf Jeffrey Alan Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2022-12-15 | MONAHAN JOHN J Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2022-12-15 | SHALLCROSS STEVEN A CEO and CFO | Grant or award · Stock Options (right to buy) | +475,000 | 475,000 | ||
| 2022-12-15 | Tufaro Francis Chief Operating Officer | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2021-12-23 | Wolf Jeffrey Alan Director | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2021-12-23 | SHALLCROSS STEVEN A CEO and CFO | Grant or award · Stock Options (right to buy) | +650,000 | 650,000 | ||
| 2021-12-23 | MONAHAN JOHN J Director | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2021-12-23 | Kraws Jeffrey J Director | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2021-05-10 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +50,000 | $0.49 | $25K | 100,000 |
| 2020-12-30 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2020-12-30 | SHALLCROSS STEVEN A CEO and CFO | Grant or award · Stock Options | +450,000 | 450,000 | ||
| 2020-12-30 | MONAHAN JOHN J Director | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2020-12-30 | Kraws Jeffrey J Director | Grant or award · Stock Options | +150,000 | 150,000 | ||
| 2019-12-04 | Tarriff Scott Director | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2019-12-04 | Kraws Jeffrey J Director | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2019-12-04 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +250,000 | 250,000 | ||
| 2019-12-04 | SHALLCROSS STEVEN A CEO and CFO | Grant or award · Stock Options | +450,000 | 450,000 | ||
| 2019-08-23 | SHALLCROSS STEVEN A CEO and CFO | Purchase | +50,000 | $0.42 | $21K | 50,000 |
| 2019-04-03 | KIRK RANDAL J 10% owner | Sale | −26,080 | $0.65 | $17K | 62,342 |
| 2019-04-03 | KIRK RANDAL J 10% owner | Sale | −69,161 | $0.65 | $45K | 165,332 |
Page 2 of 6 · 113 trades